The St. Louis surgical instrument maker has secured federal approval for a robotically-navigated device that aims to expand ...
The Pitt season premiere, "7:00 a.m.," ignores clichés in favor of a gritty, realistic, and uncompromising take on the ...
FDA approval of MAGiC is a significant milestone for Stereotaxis and the community of physicians pioneering robotics in electrophysiology. It ensures the benefits of Robotic Magnetic Navigation can ...
Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒‒ FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million ‒‒ Expects ...
Under the leadership of Mr. Todisco, CorMedix has evolved from a single product, development stage company into a multi-product, diversified commercial operation with positive cashflow and a strong ...
CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...
Stocktwits on MSN
Why did CRMD stock crash 28% today?
The outlook includes $150 million to $170 million from DefenCath, with results weighted toward the first half of the year. ・The company expects adjusted EBITDA for 2026 to be between $100 million and ...
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks Jim Cramer offered insights on. Toward the end of the lightning round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback